Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism

Alisdair Boag, Andrea Short, Lorna J Kennedy, Hattie Syme, Peter Graham, Brian Catchpole

Research output: Contribution to journalArticlepeer-review


Canine hypoadrenocorticism is an immune-mediated endocrinopathy that shares both clinical and pathophysiological similarities with Addison’s disease in humans. Several dog breeds are overrepresented in the disease population, suggesting that a genetic component is involved, although this is likely to be polygenic. Previous research has implicated CTLA4 as a potential susceptibility gene. CTLA4 is an important regulator of T cell function and polymorphisms/mutations in CTLA4 have been associated with a number of autoimmune phenotypes in both humans and rodent models of autoimmunity. The aim of the current study was to undertake a case:control association study of CTLA4 promotor polymorphisms in three dog breeds, cocker spaniels, springer spaniels and West Highland white terriers (WHWT).

Polymorphisms in the CTLA4 promoter were determined by PCR and sequence-based typing. There were significant associations with three promoter haplotypes in cocker spaniels (p = 0.003). A series of SNPs were also associated with hypoadrenocorticism in cocker spaniels and springer spaniels, including polymorphisms in predicted NFAT and SP1 transcription factor binding sites.

This study provides further evidence that CTLA4 promotor polymorphisms are associated with this complex genetic disease and supports an immune mediated aetiopathogenesis of canine hypoadrenocorticism.
Original languageEnglish
JournalCanine Medicine and Genetics
Publication statusPublished - 4 Mar 2020


  • Addison’s, Canine
  • CTLA-4
  • Hypoadrenocorticism
  • Promoter


Dive into the research topics of 'Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism'. Together they form a unique fingerprint.

Cite this